ConforMIS (CFMS) began trading on Nasdaq on 1 July 2015

• ConforMIS, which makes customized knee replacement implants, sold nine million shares at a price of $15 each. The stock rose to $19.25 by the end of trading Wednesday, giving the company a market value of about $750 million.
• The company, founded in 2004 in Redwood City, Calif., moved to Massachusetts in 2008. It reported $48 million in sales and a loss of nearly $46 million last year.
• Joint bookrunners for the offering are JPMorgan and Deutsche Bank. Co-managers are Wells Fargo Securities, Canaccord Genuity and Oppenheimer. The underwriters have a 30-day option to purchase an additional 1.35 million shares.

• charts 24 March 2017 (1 year 9 months after IPO)